Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Deferred Taxes: 2014-2025

Historic Deferred Taxes for Surgery Partners (SGRY) over the last 12 years, with Q3 2025 value amounting to $5.1 million.

  • Surgery Partners' Deferred Taxes rose 8888.89% to $5.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 million, marking a year-over-year decrease of 7656.25%. This contributed to the annual value of $131.5 million for FY2024, which is 783529.41% up from last year.
  • According to the latest figures from Q3 2025, Surgery Partners' Deferred Taxes is $5.1 million, which was up 8888.89% from -$1.5 million recorded in Q2 2025.
  • In the past 5 years, Surgery Partners' Deferred Taxes registered a high of $121.2 million during Q4 2024, and its lowest value of -$9.7 million during Q2 2023.
  • Moreover, its 5-year median value for Deferred Taxes was $2.5 million (2024), whereas its average is $8.6 million.
  • Per our database at Business Quant, Surgery Partners' Deferred Taxes plummeted by 34871.79% in 2023 and then skyrocketed by 123186.81% in 2024.
  • Surgery Partners' Deferred Taxes (Quarter) stood at $11.2 million in 2021, then dropped by 15.18% to $9.5 million in 2022, then dropped by 4.21% to $9.1 million in 2023, then surged by 1231.87% to $121.2 million in 2024, then plummeted by 95.79% to $5.1 million in 2025.
  • Its Deferred Taxes was $5.1 million in Q3 2025, compared to -$1.5 million in Q2 2025 and -$300000.0 in Q1 2025.